Eureka Acquisition Corp Class A Ordinary Share (EURK) 10-Q 14 Aug 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Jun. 30, 2024	Aug. 14, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	Eureka Acquisition Corp
Entity Central Index Key	0002000410
Entity File Number	001-42152
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	Suite 1608
Entity Address, Address Line Two	16th FloorFortress Tower
Entity Address, Address Line Three	250 King’s RoadNorth Point
Entity Address, City or Town	Hong Kong
Entity Address, Country	HK
Entity Address, Postal Zip Code	00000
Entity Phone Fax Numbers [Line Items]
City Area Code	(+1)
Local Phone Number	949 899 1827
Units, consisting of one Ordinary Share, $0.0001 par value, and one Right to acquire one-fifth of one Ordinary Share
Entity Listings [Line Items]
Title of 12(b) Security	Units, consisting of one Ordinary Share, $0.0001 par value, and one Right to acquire one-fifth of one Ordinary Share
Trading Symbol	EURKU
Security Exchange Name	NASDAQ
Class A ordinary shares, par value $0.0001 per share
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	EURK
Security Exchange Name	NASDAQ
Rights, each whole right to acquire one-fifth of one Class A ordinary share
Entity Listings [Line Items]
Title of 12(b) Security	Rights, each whole right to acquire one-fifth of one Class A ordinary share
Trading Symbol	EURKR
Security Exchange Name	NASDAQ
Class A ordinary shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		6,208,000
Class B ordinary shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		1,437,500

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)		Jun. 30, 2024	Sep. 30, 2023
Current Assets
Cash		$ 57,877
Prepaid expenses		7,474	47,200
Total Current Assets		65,351	47,200
Non-current Assets
Deferred offering costs		224,306	236,902
Total Assets		289,657	284,102
Current Liabilities
Accounts payable and accrued expenses		13,163	160,416
Total Current Liabilities		383,230	264,427
Total Liabilities		383,230	264,427
Commitments and Contingencies (Note 6)
Shareholder’s (Deficit) Equity:
Preference shares, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding
Additional paid-in capital		24,856	24,856
Accumulated deficit		(118,573)	(5,325)
Total Shareholder’s (Deficit) Equity		(93,573)	19,675
Total Liabilities and Shareholders’ (Deficit) Equity		289,657	284,102
Related Party
Current Liabilities
Due to related party		1,056
Promissory note – related party		369,011	104,011
Class A Ordinary Shares
Shareholder’s (Deficit) Equity:
Ordinary shares, value
Class B Ordinary Shares
Shareholder’s (Deficit) Equity:
Ordinary shares, value	[1]	$ 144	$ 144
[1] This number includes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares		Jun. 30, 2024	Sep. 30, 2023
Preference shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Preference shares, shares authorized		10,000,000	10,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Ordinary shares, shares authorized		390,000,000	390,000,000
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	[1]	100,000,000	100,000,000
Ordinary shares, shares issued	[1]	1,437,500	1,437,500
Ordinary shares, shares outstanding	[1]	1,437,500	1,437,500
[1] This number includes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Unaudited Condensed Statements

Unaudited Condensed Statements of Operations - USD ($)		1 Months Ended	3 Months Ended	9 Months Ended
		Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2024
Formation and operating costs		$ 3,957	$ 29,349	$ 113,248
Net loss		$ (3,957)	$ (29,349)	$ (113,248)
Class B Ordinary Shares
Basic weighted average shares outstanding (in Shares)	[1]	1,250,000	1,250,000	1,250,000
Basic net loss per ordinary share (in Dollars per share)		$ 0	$ (0.02)	$ (0.09)
[1] This number excludes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Unaudited Condensed Statement_2

Unaudited Condensed Statements of Operations (Parentheticals) - Class B Ordinary Shares - $ / shares		1 Months Ended	3 Months Ended	9 Months Ended
		Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2024
Diluted weighted average shares outstanding	[1]	1,250,000	1,250,000	1,250,000
Diluted net loss per ordinary share		$ 0	$ (0.02)	$ (0.09)
[1] This number excludes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Unaudited Condensed Statement_3

Unaudited Condensed Statements of Changes in Shareholder’s Equity (Deficit) - USD ($)		Preference Shares	Ordinary Shares Class A	Ordinary Shares Class B		Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Jun. 12, 2023
Balance (in Shares) at Jun. 12, 2023					[1]
Founder shares issued to initial shareholders	[1]			$ 144		24,856		25,000
Founder shares issued to initial shareholders (in Shares)	[1]			1,437,500
Net loss							(3,957)	(3,957)
Balance at Jun. 30, 2023				$ 144		24,856	(3,957)	21,043
Balance (in Shares) at Jun. 30, 2023				1,437,500	[1]
Balance at Sep. 30, 2023				$ 144		24,856	(5,325)	19,675
Balance (in Shares) at Sep. 30, 2023				1,437,500	[1]
Net loss							(113,248)	(113,248)
Balance at Jun. 30, 2024				$ 144		24,856	(118,573)	(93,573)
Balance (in Shares) at Jun. 30, 2024				1,437,500	[1]
Balance at Mar. 31, 2024				$ 144		24,856	(89,224)	(64,224)
Balance (in Shares) at Mar. 31, 2024				1,437,500	[1]
Net loss							(29,349)	(29,349)
Balance at Jun. 30, 2024				$ 144		$ 24,856	$ (118,573)	$ (93,573)
Balance (in Shares) at Jun. 30, 2024				1,437,500	[1]
[1] This number includes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Unaudited Condensed Statement_4

Unaudited Condensed Statements of Cash Flows - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net loss	$ (113,248)	$ (3,957)
Adjustment to reconcile net loss to net cash used in operating activities:
Formation costs paid via promissory note – related party		3,957
Changes in operating assets and liabilities:
Prepaid expenses	39,726
Accounts payable and accrued expenses	13,163
Net Cash Used in Operating Activities	(60,359)
Cash Flows from Financing Activities:
Borrowings via promissory note – related party	265,000
Payment of deferred offering costs	(146,764)
Net Cash Provided by Financing Activities	118,236
Net Change in Cash	57,877
Cash, beginning of period
Cash, end of period	57,877
Supplemental Disclosure of Cash Flow Information:
Reversal of deferred offering cost being waived	(100,000)
Deferred offering costs paid via promissory note – related party		50,000
Formation costs paid via promissory note – related party		3,957
Formation costs paid by related party	$ 1,056

Organization, Business Operatio

Organization, Business Operation and Going Concern Consideration	9 Months Ended
	Jun. 30, 2024
Organization, Business Operation and Going Concern Consideration [Abstract]
Organization, Business Operation and Going Concern Consideration	Note 1 — Organization, Business Operation and Going Concern Consideration Eureka Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on June 13, 2023. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which is referred to as a “target business.” (the “Business Combination”) The Company does not have any specific Business Combination under consideration and the Company has not (nor has anyone on its behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic location but will initially focus in Asia. The Company may consummate a Business Combination with an entity located in People’s Republic of China (“PRC” including Hong Kong and Macau). Further, due to the fact that a majority of the Company’s executive officers and directors are located in or have significant ties to China, it may make us a less attractive partner to certain potential target businesses, including non-China or non-Hong Kong-based target companies, and such perception may potentially limit or negatively impact its search for an initial Business Combination or may therefore make it more likely for the Company to consummate a Business Combination with a company based in or having the majority of its operations in PRC and/or Hong Kong. The Company has selected September 30 as its fiscal year end. As of June 30, 2024, the Company had not commenced any operations. For the period from June 13, 2023 (inception) through June 30, 2024, the Company’s efforts have been limited to organizational activities as well as activities related to the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO and sale of Private Units (as defined below). The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s founder and sponsor is Hercules Capital Management Corp, a British Virgin Islands company (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through the IPO (see Note 3) and a private placement to the initial shareholder (see Note 4). On July 3, 2024, the Company consummated its IPO of 5,000,000 units (“Units”). Each Unit consists of one Class A ordinary share, $0.0001 par value per share, and one right to receive one-fifth of one Class A ordinary share upon the completion of the initial Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $50,000,000. On July 3, 2024, the underwriter notified the Company of its exercise of the over-allotment option in full to purchase additional 750,000 Units (the “Option Units”) of the Company (the “Over-Allotment Option”). As a result, on July 8, 2024, 750,000 Units were sold to the underwriter at an offering price of $10.00 per Option Unit (the “Option Units” and together with the Units, collectively, the “Public Units”), generating gross proceeds of $7,500,000. Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement of 216,750 units (the “Initial Private Placement Units”) to the Sponsor, at a price of $10.00 per Initial Private Placement Unit, generating total proceeds of $2,167,500, which is described in Note 4. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of additional 11,250 units (the “Additional Private Units” and together with the Initial Private Placement Units, collectively, the “Private Units”) to the Sponsor at a purchase price of $10.00 per Additional Private Unit, generating gross proceeds of $112,500. Transaction costs amounted to $1,449,114 consisting of $750,000 of underwriting commissions which was paid in cash at the closing date of the IPO, $262,000 of the Representative Shares (discussed in the below), and $437,114 of other offering costs. At the closing date of the IPO and Over-allotment Option, cash of $827,216 was held outside of the Trust Account (as defined below) and is available for the payment of accrued offering costs and for working capital purposes. In conjunction with the IPO, the Company issued to the underwriter 200,000 Class A ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the closing date of the IPO totaled $1,949,000. In connection with the issuance and sales of the Option Units, the Company issued an additional 30,000 Representative Shares to the underwriter. The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the balance in the Trust Account (as defined below), (less any taxes payable on interest earned) at the time of execution of the definitive agreement in connection with its initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company does not believe that its anticipated principal activities will subject the Company to the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. Upon the closing of the IPO, management has agreed that at least $10.00 per Public Unit sold in the IPO would be held into a U.S.-based trust account (“Trust Account”). The funds held in the Trust Account will be invested only in U.S. government treasury bills with a maturity of 185 days or less, or in money market funds meeting the applicable conditions of Rule 2a-7 promulgated under the Investment Company Act which invest solely in direct U.S. government treasury or in an interest bearing or non-interest bearing demand deposit account. Except with respect to divided and/or interest earned on the funds held in the Trust Account that may be released to the Company to pay the Company’s tax obligation, if any, the proceeds from the IPO and the sale of the Private Units that are deposited and held in the Trust Account will not be released from the Trust Account until the earliest to occur of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of obligation to redeem 100% of our public shares if the Company does not complete the Company’s initial Business Combination by July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination two times, each by an additional three months) (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the Company’s public shares if the company are unable to complete their initial Business Combination within Combination Period, subject to applicable law. In no other circumstances will a public shareholder have any right or interest of any kind to or in the Trust Account. The Company will provide the holders of public shares with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The Company has determined not to consummate any Business Combination unless the Company has net tangible assets of at least $5,000,001 upon such consummation in order to avoid being subject to Rule 419 promulgated under the Securities Act. However, if the Company seeks to consummate an initial Business Combination with a target business that imposes any type of working capital closing condition or requires us to have a minimum amount of funds available from the Trust Account upon consummation of such initial Business Combination, its net tangible asset threshold may limit the Company’s ability to consummate such initial Business Combination (as the Company may be required to have a lesser number of shares redeemed) and may force the Company to seek third party financing which may not be available on terms acceptable to the Company or at all. As a result, the Company may not be able to consummate such an initial Business Combination and the Company may not be able to locate another suitable target within the applicable time period, if at all. The Company will have until July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination two times, each by an additional three months) to complete its initial Business Combination. If the Company is unable to complete its initial Business Combination by July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination two times, each by an additional three months), the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $50,000 of interest to pay dissolution expenses (which interest shall be net of taxes payable) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of its remaining shareholders and its Board of Directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to its public rights or private placement rights, which will expire worthless if the Company fails to complete its initial Business Combination by July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination two times, each by an additional three months). Pursuant to the terms of the Company’s amended and restated memorandum and articles of association, in order to extend the time available for the Company to consummate its initial Business Combination, its sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit an aggregate of $575,000 ($0.10 per public share), on or prior to the date of the applicable deadline, for each three-month extension (or up to an aggregate of $1,150,000. Going Concern Consideration As of June 30, 2024, the Company had $57,877 of cash and a working capital deficiency of $317,879. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. In addition, the Company initially has until July 3, 2025 to consummate the initial Business Combination (assume no extensions). If the Company does not complete a Business Combination within the Combination Period, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. Notwithstanding management’s belief that the Company would have sufficient funds to execute its business strategy, there is a possibility that Business Combination might not happen within the 12-month period from the issuance date of these financial statements. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, management has determined that such additional condition raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. The financial statements do not include any adjustments that might result from the Company’s inability to consummate the initial Business Combination to continue as a going concern. Risks and Uncertainties As a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions as well as the impact of armed conflict in Israel and the Gaza Strip commenced in October 2023, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Jun. 30, 2024
Significant Accounting Policies [Abstract]
Significant accounting policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for a fair presentation of the financial statements, have been included. Interim results for the nine months ended June 30, 2024 are not necessarily indicative of results to be expected for the full year. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The cash and cash equivalents were $57,877 as of June 30, 2024, the Company did not have any cash or cash equivalents as of September 30, 2023. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. Deferred Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — Expenses of Offering Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 187,500 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). As of June 30, 2024 and September 30, 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. ● Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. ● Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. ● Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as stockholders’ equity. In accordance with ASC 480-10-S99, the Company classifies the Class A ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the 5,750,000 Class A ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of Class A ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in-capital over an expected 12-month period, which is the initial period that the Company has to complete Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Stock-based compensation The Company recognizes compensation costs resulting from the issuance of stock-based awards to directors as an expense in the financial statement over the requisite service period based on a measurement of fair value for each stock-based award. The fair value is amortized as compensation cost on a straight-line basis over the requisite service period of the awards. The Black-Scholes-Merton option-pricing model includes various assumptions, including the fair market value of the estimated stock price of the Company, expected life of shares, the expected volatility and the expected risk-free interest rate, among others. These assumptions reflect the Company’s best estimates, but they involve inherent uncertainties based on market conditions generally outside the control of the Company. Related parties Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Recent Accounting Pronouncements In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Jun. 30, 2024
Initial Public Offering [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering On July 3, 2024, the Company sold 5,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share, par value $0.0001 per share and one right (the “Public Right”). Each Public Right entitles the holder to purchase one-fifth (1/5) of one Class A ordinary share upon the consummation of the Company’s initial Business Combination. The Company will not issue fractional shares. As a result, the holder must hold Public Rights in multiples of five (5) in order to receive shares for all of their Public Rights upon closing of a Business Combination. The Company had also granted the underwriters a 45-day option to purchase up to an additional 750,000 units to cover over-allotments, if any. On July 3, 2024, the underwriter notified the Company of its exercise of Over-Allotment Option in full to purchase additional 750,000 Option Units of the Company. On July 8, 2024, 750,000 Option Units were sold to the underwriter at an offering price of $10.00 per Option Unit, generating gross proceeds of $7,500,000.

Private Placement

Private Placement	9 Months Ended
	Jun. 30, 2024
Private Placement [Abstract]
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 216,750 Initial Private Placement Units at a price of $10.00 per Initial Private Placement Units for an aggregate purchase price of $2,167,500. Each Initial Private Placement Unit was identical to the Public Units sold in the IPO, except as described below. Simultaneously with the closing of the Option Units on July 8, 2024, the Company consummated the sale of additional 11,250 Additional Private Placement Units to the Sponsor at a price of $10.00 per Additional Private Placement Unit, generating total proceeds of $112,500. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Founder Shares (as defined below), the Class A ordinary shares included in the Private Units (the “Private Shares”) or private placement rights. The rights will expire worthless if the Company does not consummate a Business Combination by July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination up to two times, each by an additional three months). Each Private Unit are identical to the Public Units sold in the IPO, except that it will not be redeemable, transferable, assignable or salable by the Sponsor until the completion of its initial Business Combination, except in each case (a) to the Company’s officers or directors, any affiliates or family members of any of its officers or directors, any members of the Sponsor, or any affiliates of the Sponsor, (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; or (f) by virtue of the laws of the Cayman Islands or the Sponsor’s operating agreement upon dissolution of the Sponsor; provided, however, that in the case of clauses (a) through (e) or (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and by the same agreements entered into by the Sponsor with respect to such securities (including provisions relating to voting and liquidation distributions).

Related Party Transactions

Related Party Transactions	9 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On July 4, 2023 and September 29, 2023, the Sponsor acquired 100 and 1,437,400 Class B ordinary share (the “Founder Shares”), respectively, for an aggregate purchase price of $25,000, or approximately $0.02 per share. As of June 30, 2024, there were 1,437,500 Founder Shares issued and outstanding, among which, up to 187,500 Founder Shares were subject to forfeiture if the underwriters’ over-allotment was not exercised. On July 8, 2024, the underwriters exercised their Over-Allotment Option in full, hence, all 187,500 Founder Shares were no longer subject to forfeiture. The Founder Shares are identical to the Class A ordinary shares included in the Public Units being sold in the IPO, and holders of Founder Shares have the same shareholder rights as public shareholders, except that (i) holders of the Founder Shares have the right to vote on the election of directors prior to its initial Business Combination, (ii) the Founder Shares are subject to certain transfer restrictions, as described in more detail below, and (iii) the Sponsor, officers and directors of the Company have entered into a letter agreement with the Company, pursuant to which they have agreed (A) to waive their redemption rights with respect to the Founder Shares, Private Shares and public shares in connection with the completion of its initial Business Combination and (B) to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Shares if the Company fails to complete its initial Business Combination by July 3, 2025 (or up to January 3, 2026 if the Company extends the period of time to consummate a Business Combination up to two times, each by an additional three months), although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within such time period and (iii) the Founder Shares and Private Shares are subject to registration rights. If the Company submits its initial Business Combination to its public shareholders for a vote, the Sponsor, and its officers and directors have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with the Company, to vote any Founder Shares and the Private Shares held by them and any public shares purchased during or after the IPO in favor of its initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of its initial Business Combination on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein and in its amended and restated memorandum and articles of association. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the IPO and related to the closing of the Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares outstanding upon completion of the IPO (excluding the Private Shares and the Representative Shares) plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any private placement-equivalent units issued to its sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time. The term “equity-linked securities” refers to any debt or equity securities that are convertible, exercisable or exchangeable for its Class A ordinary shares issued in a financing transaction in connection with its initial Business Combination, including but not limited to a private placement of equity or debt. Securities could be “deemed issued” for purposes of the conversion adjustment if such shares are issuable upon the conversion or exercise of convertible securities, warrants or similar securities. With certain limited exceptions, the Founder Shares are not transferable, assignable or saleable (except to the permitted transferees, each of whom will be subject to the same transfer restrictions) until the earlier of (1) six months after the completion of its initial Business Combination and (2) the date on which the Company consummates a liquidation, merger, share exchange, reorganization, or other similar transaction after its initial Business Combination that results in all of its shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period after the Company’s initial Business Combination, 50% of the Founder shares will be released from the lock-up. As of June 30, 2024, the Sponsor has paid for the expenses incurred by the Company in the amount of $1,056, which is non-interest bearing and is due on demand. Promissory Note — Related Party On September 30, 2023, the Sponsor has agreed to loan the Company up to $500,000 (the “Promissory Note”) to be used for a portion of the expenses of the IPO. As of June 30, 2024 and September 30, 2023, the Company has an outstanding loan balance of $369,011 and $104,011, respectively. This loan is non-interest bearing, unsecured and is due at the earlier of (1) the closing of the IPO or (2) the date on which the Company determines not to conduct an initial public offering of its securities, unless accelerated upon the occurrence of an Event of Default. The outstanding loan balance of $369,011 was repaid upon the closing of the IPO out of the offering proceeds not held in the Trust Account on July 3, 2024. Working Capital Loans In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such working capital loans (“Working Capital Loans”) made by the Sponsor, the Company’s officers and directors, or the Company’s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Private Units. As of June 30, 2024 and September 30, 2023, the Company had no borrowings under the Working Capital Loans. Administrative Support Services Commencing on the effective date of the registration statement of the IPO, the Company has agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of its initial Business Combination or its liquidation, the Company will cease paying these monthly fees.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 6 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Representative Shares, Private Units, and units that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) are entitled to registration rights pursuant to a registration rights agreement on July 2, 2024 requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to its completion of its initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company had granted the underwriter a 45-day option from the date of IPO to purchase up to an additional 750,000 Option Units to cover over-allotments, if any. On July 8, 2024, the underwriters exercised the Over-Allotment Option in full. The underwriter was entitled to a cash underwriting discount of $0.15 per unit, or $750,000 (or up to $862,500 if the underwriters’ over-allotment is exercised in full). Additionally, the underwriters was entitled to acquire the Company’s 200,000 Class A ordinary shares (or up to 230,000 shares of Class A ordinary shares if the underwriters’ over-allotment is exercised in full) that were registered in the IPO and were paid at the closing of the IPO as the Representative Shares. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of its initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the Combination Period. In connection with the IPO, the Company issued 200,000 Representative Shares to the underwriter with a fair value of $262,000. In connection with the issuance and sales of the Option Units, the Company issued an additional 30,000 Representative Shares to the underwriter with a fair value of $39,000.

Shareholder's Equity

Shareholder's Equity	9 Months Ended
	Jun. 30, 2024
Shareholder's Equity [Abstract]
Shareholder's Equity	Note 7 — Shareholder’s Equity Preference Share no Class A Ordinary Share no Class B Ordinary Share Prior to the initial Business Combination, only holders of Class B ordinary shares will have the right to vote in the election of directors. Holders of its Class A ordinary shares will not be entitled to vote on the election of directors during such time. These provisions of the Company’s amended and restated memorandum and articles of association with class rights may not be amended without a resolution passed by holders of at least two thirds of the Company’s ordinary shares who are eligible to vote and attend and vote in a general meeting of the Company’s shareholders. With respect to any other matter submitted to a vote of its shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of the Founder Shares and holders of its Class A ordinary shares will vote together as a single class, with each share entitling the holder to one vote. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to the Company’s amended and restated memorandum and articles of association. Rights Each holder of a right will receive one-fifth (1/5) of one Class A ordinary share upon consummation of its initial Business Combination, even if the holder of such right redeemed all Class A ordinary shares held by it in connection with the initial Business Combination. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of an initial Business Combination, as the consideration related thereto has been included in the unit purchase price paid for by investors in the IPO. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the Class A ordinary shares will receive in the transaction on an as-converted into ordinary share basis, and each holder of a right will be required to affirmatively convert its rights in order to receive the one-fifth (1/5) share underlying each right (without paying any additional consideration) upon consummation of the Business Combination. More specifically, the right holder will be required to indicate its election to convert the rights into underlying shares as well as to return the original rights certificates to the Company. The shares issuable upon conversion of the rights will be freely tradable (except to the extent held by affiliates of the Company). The Company will not issue fractional shares upon conversion of the rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. As a result, the holders of rights must hold rights in multiples of five (5) in order to receive shares for all of their rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. Accordingly, the rights may expire worthless.

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these unaudited condensed financial statements were issued. Based on this review, except as disclosed below, the Company did not identify any other subsequent events that would require adjustment or disclosure in the financial statements. On July 1, 2024, the effective date of the registration statement of the IPO, the Sponsor transferred an aggregate of 30,000 of its Founder Shares, or 10,000 each to its three independent directors for their board service, for nominal cash consideration, of $522. On July 3, 2024, the Company consummated its IPO of 5,000,000 Units at an offering price of $10.00 per Unit, generating total gross proceeds of $50,000,000. Simultaneously with the closing of the IPO, the Company consummated the private placement of 216,750 Initial Private Placement Units to the Sponsor, at a price of $10.00 per Initial Private Placement Unit, generating total proceeds of $2,167,500. On July 3, 2024, the underwriter notified the Company of its exercise of the over-allotment option in full to purchase an additional 750,000 Option Unit. As a result, on July 8, 2024, 750,000 Option Units were sold to the underwriter at an offering price of $10.00 per Option Unit generating gross proceeds of $7,500,000. Concurrently with the underwriter’s exercise of such option, the Company completed a private placement sale of additional 11,250 Additional Private Units to the Sponsor at a purchase price of $10.00 per Additional Private Unit, generating gross proceeds of $112,500. On July 3, 2024, the Company repaid the outstanding loan balance of $481,511 to the Sponsor upon the closing of the IPO.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (3,957)	$ (29,349)	$ (113,248)	$ (3,957)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Jun. 30, 2024
Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for a fair presentation of the financial statements, have been included. Interim results for the nine months ended June 30, 2024 are not necessarily indicative of results to be expected for the full year.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The cash and cash equivalents were $57,877 as of June 30, 2024, the Company did not have any cash or cash equivalents as of September 30, 2023.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.
Deferred Offering Costs	Deferred Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — Expenses of Offering
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of 187,500 ordinary shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). As of June 30, 2024 and September 30, 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. ● Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. ● Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. ● Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Class A ordinary shares subject to possible redemption	Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as stockholders’ equity. In accordance with ASC 480-10-S99, the Company classifies the Class A ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the 5,750,000 Class A ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of Class A ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in-capital over an expected 12-month period, which is the initial period that the Company has to complete
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Stock-based compensation	Stock-based compensation The Company recognizes compensation costs resulting from the issuance of stock-based awards to directors as an expense in the financial statement over the requisite service period based on a measurement of fair value for each stock-based award. The fair value is amortized as compensation cost on a straight-line basis over the requisite service period of the awards. The Black-Scholes-Merton option-pricing model includes various assumptions, including the fair market value of the estimated stock price of the Company, expected life of shares, the expected volatility and the expected risk-free interest rate, among others. These assumptions reflect the Company’s best estimates, but they involve inherent uncertainties based on market conditions generally outside the control of the Company.
Related parties	Related parties Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Organization, Business Operat_2

Organization, Business Operation and Going Concern Consideration (Details) - USD ($)			9 Months Ended	12 Months Ended
	Jul. 08, 2024	Jul. 03, 2024	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Organization, Business Operation and Going Concern Consideration [Line Items]
Gross proceeds			$ 265,000
Transaction costs			1,449,114
Underwriting commissions			750,000
Representative shares			$ 262,000
Percentage of fair market value of the balance in the trust account			80%
Obligation to redeem public shares if entity does not complete a business combination			100%
Condition for future business combination threshold net tangible assets			$ 5,000,001
Interest to pay dissolution expenses			50,000
Deposit			575,000
Cash			57,877
Working capital deficiency			317,879
Maximum [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Deposit			$ 1,150,000
Business Combination [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Outstanding voting percentage			50%
Other offering costs [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Sale of Stock Other Offering Costs			$ 437,114
Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of Shares Right to Receive Upon Completion of initial Business Combination		one-fifth
Class A Ordinary Shares [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Share par value (in Dollars per share)			$ 0.0001		$ 0.0001
Class A Ordinary Shares [Member] | Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Price per share (in Dollars per share)		$ 10
Public Shares [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Price per share (in Dollars per share)			$ 0.1
IPO [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)		5,000,000
Gross proceeds		$ 50,000,000	$ 1,949,000
IPO [Member] | Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Gross proceeds		$ 50,000,000
IPO [Member] | Class A Ordinary Shares [Member] | Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)		5,000,000
Each unit will be separated into (in Shares)		1
Share par value (in Dollars per share)		$ 0.0001
Price per share (in Dollars per share)		$ 10
Over-Allotment Option [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)		750,000	750,000
Over-Allotment Option [Member] | Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)		750,000
Underwriter [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Representative shares			$ 30,000
Underwriter [Member] | Subsequent Event [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)	750,000
Price per share (in Dollars per share)	$ 10
Gross proceeds	$ 7,500,000
Underwriter [Member] | Class A Ordinary Shares [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of share issued (in Shares)			200,000
Private Placement [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)		216,750
Gross proceeds		$ 2,167,500
Private Placement [Member] | Sponsor [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Number of units issued (in Shares)	11,250		216,750
Price per share (in Dollars per share)	$ 10		$ 10
Gross proceeds	$ 112,500		$ 2,167,500
IPO and Over-allotment Option [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Cash			$ 827,216
Public Unit [Member]
Organization, Business Operation and Going Concern Consideration [Line Items]
Price per share (in Dollars per share)			$ 10

Significant Accounting Polici_2

Significant Accounting Policies (Details)	9 Months Ended
	Jun. 30, 2024 USD ($) shares
Significant Accounting Policies [Line Items]
Cash and cash equivalents | $	$ 57,877
Federal depository insurance coverage | $	$ 250,000
Over-Allotment Option [Member]
Significant Accounting Policies [Line Items]
Shares subject to forfeiture | shares	187,500
Temporary equity | shares	5,750,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)			9 Months Ended
	Jul. 08, 2024	Jul. 03, 2024	Jun. 30, 2024
IPO [Member]
Initial Public Offering [Line Items]
Number of units issued		5,000,000
Gross proceeds (in Dollars)		$ 50,000,000	$ 1,949,000
IPO [Member] | Subsequent Event [Member]
Initial Public Offering [Line Items]
Gross proceeds (in Dollars)		$ 50,000,000
IPO [Member] | Class A Ordinary Shares [Member] | Subsequent Event [Member]
Initial Public Offering [Line Items]
Number of units issued		5,000,000
price per share (in Dollars per share)		$ 10
Each unit will be separated into		1
Ordinary shares, par value (in Dollars per share)		$ 0.0001
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Number of units issued		750,000	750,000
Underwriters option period from the date of initial public offering			45 days
Over-Allotment Option [Member] | Subsequent Event [Member]
Initial Public Offering [Line Items]
Number of units issued		750,000
Underwriter [Member] | Subsequent Event [Member]
Initial Public Offering [Line Items]
Number of units issued	750,000
price per share (in Dollars per share)	$ 10
Gross proceeds (in Dollars)	$ 7,500,000

Private Placement (Details)

Private Placement (Details) - Private Placement [Member] - Sponsor [Member] - USD ($)		9 Months Ended
	Jul. 08, 2024	Jun. 30, 2024
Private Placement [Line Items]
Number of units issued	11,250	216,750
Share price per unit	$ 10	$ 10
Total proceed	$ 112,500	$ 2,167,500

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)						9 Months Ended
	Jul. 08, 2024	Jul. 03, 2024	Sep. 30, 2023	Sep. 29, 2023	Jul. 04, 2023	Jun. 30, 2024	Jul. 31, 2023
Related Party Transactions [Line Items]
Ordinary shares equals or exceeds per share (in Dollars per share)						$ 12
Outstanding loan repaid		$ 369,011
Working capital loan						$ 1,500,000
Convertible units (in Dollars per share)						$ 10
Founder Shares [Member]
Related Party Transactions [Line Items]
Aggregate price				$ 25,000	$ 25,000
Price per share (in Dollars per share)				$ 0.02	$ 0.02
Founder shares issued (in Shares)						1,437,500
Founder shares outstanding (in Shares)						1,437,500
Trading days						20 days
After the initial business combination trading days						30 days
Initial business combination percenatge						50%
Related Party [Member]
Related Party Transactions [Line Items]
Due to a related party						$ 1,056
Sponsor [Member]
Related Party Transactions [Line Items]
Outstanding loan balance			$ 104,011			369,011
Administrative Support Services [Member]
Related Party Transactions [Line Items]
Administrative expense						$ 10,000
Maximum [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Loan			$ 500,000
Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Founder shares issued (in Shares)			1,437,500				1,437,500
Class B Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Acquired shares (in Shares)				1,437,400
Class B Ordinary Shares [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Acquired shares (in Shares)					100
Class A Ordinary Shares [Member]
Related Party Transactions [Line Items]
Percentage of ordinary shares outstanding						20%
Over-Allotment Option [Member]
Related Party Transactions [Line Items]
Shares were subject to forfeiture (in Shares)						187,500
Over-Allotment Option [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Shares were subject to forfeiture (in Shares)	187,500	187,500

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	9 Months Ended
	Jun. 30, 2024	Jul. 03, 2024
Underwriting Agreement [Member]
Commitments and Contingencies [Line Items]
Underwriting discount per unit (in Dollars per share)	$ 0.15
Underwriter cash discount (in Dollars)	$ 750,000
Representative Shares [Member]
Commitments and Contingencies [Line Items]
Number of shares issued	30,000
Fair value (in Dollars)	$ 39,000
Over-Allotment Option [Member]
Commitments and Contingencies [Line Items]
Underwriters option period from the date of proposed public offering	45 days
Number of units issued	750,000	750,000
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Commitments and Contingencies [Line Items]
Cash underwriting discount (in Dollars)	$ 862,500
Over-Allotment Option [Member] | Class A Ordinary Shares [Member] | Underwriting Agreement [Member]
Commitments and Contingencies [Line Items]
Number of units issued	200,000
Underwriters share acquired	230,000
Underwriter [Member] | Class A Ordinary Shares [Member]
Commitments and Contingencies [Line Items]
Number of shares issued	200,000
Underwriter [Member] | Representative Shares [Member]
Commitments and Contingencies [Line Items]
Number of shares issued	200,000
Fair value (in Dollars)	$ 262,000

Shareholder's Equity (Details)

Shareholder's Equity (Details) - USD ($)						9 Months Ended
		Jul. 08, 2024	Jul. 03, 2024	Sep. 30, 2023	Jul. 31, 2023	Jun. 30, 2024
Shareholder’s Equity [Line Items]
Preference shares, shares authorized				10,000,000		10,000,000
Preference shares, par value (in Dollars per share)				$ 0.0001		$ 0.0001
Preference shares, shares issued
Preference shares, shares outstanding
Purchase price of founder shares (in Dollars)				$ 25,000	$ 25,000
Percentage of shares own by initial shareholder						20%
Voting rights						one
Founder Shares [Member]
Shareholder’s Equity [Line Items]
Founder shares issued						1,437,500
Share price per share (in Dollars per share)				$ 0.02	$ 0.02
Class A Ordinary Shares [Member]
Shareholder’s Equity [Line Items]
Ordinary shares, shares authorized				390,000,000		390,000,000
Ordinary shares, par value (in Dollars per share)				$ 0.0001		$ 0.0001
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Class B Ordinary Shares [Member]
Shareholder’s Equity [Line Items]
Ordinary shares, shares authorized	[1]			100,000,000		100,000,000
Ordinary shares, par value (in Dollars per share)	[1]			$ 0.0001		$ 0.0001
Ordinary shares, shares issued	[1]			1,437,500		1,437,500
Ordinary shares, shares outstanding	[1]			1,437,500		1,437,500
Founder shares issued				1,437,500	1,437,500
Over-Allotment Option [Member]
Shareholder’s Equity [Line Items]
Shares were subject to forfeiture						187,500
Over-Allotment Option [Member] | Founder Shares [Member]
Shareholder’s Equity [Line Items]
Shares were subject to forfeiture		187,500	187,500
[1] This number includes an aggregate of up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)				9 Months Ended	12 Months Ended
	Jul. 08, 2024	Jul. 03, 2024	Jul. 01, 2024	Jun. 30, 2024	Jun. 30, 2023
Subsequent Events [Line Items]
Gross proceeds from initial public offering (in Dollars)				$ 265,000
Repayment of outstanding loan (in Dollars)		$ 369,011
Underwriter [Member]
Subsequent Events [Line Items]
Number of units issued	750,000
Share price per unit (in Dollars per share)	$ 10
Proceeds from Stock Options Exercised (in Dollars)	$ 7,500,000
Director [Member] | Sponsor [Member]
Subsequent Events [Line Items]
Transferred shares for board services			30,000
Individual transferred shares for board services			10,000
Nominal cash consideration (in Dollars)			$ 522
IPO [Member]
Subsequent Events [Line Items]
Number of units issued		5,000,000
Offering price per share (in Dollars per share)		$ 10
Gross proceeds from initial public offering (in Dollars)		$ 50,000,000		$ 1,949,000
Repayment of outstanding loan (in Dollars)		$ 481,511
Private Placement [Member]
Subsequent Events [Line Items]
Number of units issued		216,750
Offering price per share (in Dollars per share)		$ 10
Total proceed (in Dollars)		$ 2,167,500
Private Placement [Member] | Sponsor [Member]
Subsequent Events [Line Items]
Number of units issued	11,250			216,750
Total proceed (in Dollars)	$ 112,500			$ 2,167,500
Share price per unit (in Dollars per share)	$ 10			$ 10
Over-Allotment Option [Member]
Subsequent Events [Line Items]
Number of units issued		750,000		750,000